RPHM

0.00

100.00% -18.20

Handel nachbörslich: 1.81 1.81 +

Reneo Pharmaceuticals Inc (RPHM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt RPHM? Forum Prognose

Schlusskurs vom Vortag:

$18.20

Offen:

24-Stunden-Volumen:

Relative Volume:

0.00

Marktkapitalisierung:

$6.08M

Einnahmen:

Nettoeinkommen (Verlust:

$-77.39M

KGV:

0.00

EPS:

-2.53

Netto-Cashflow:

$-63.90M

1W Leistung:

-100.00%

1M Leistung:

-100.00%

6M Leistung:

-100.00%

1J Leistung:

-100.00%

1-Tages-Spanne:

$0.00

1-Wochen-Bereich:

$0.00

52-Wochen-Spanne:

$0.00

$19.30

Reneo Pharmaceuticals Inc Stock (RPHM) Company Profile

Firmenname

Reneo Pharmaceuticals Inc

Sektor

Healthcare (1174)

Branche

Biotechnology (686)

Telefon

(858) 283-0280

Adresse

18575 JAMBOREE ROAD, IRVINE

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

RPHM's Discussions on Twitter

Vergleichen Sie RPHM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RPHM Reneo Pharmaceuticals Inc	0.00	6.08M	0	-77.39M	-63.90M	-2.53
VRTX Vertex Pharmaceuticals Inc	482.28	124.20B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	697.05	76.60B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	651.30	39.57B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	271.00	34.95B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.14	28.08B	3.30B	-501.07M	1.03B	-2.1146

Reneo Pharmaceuticals Inc Stock (RPHM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-05	Eingeleitet	Leerink Partners	Outperform
2024-10-10	Eingeleitet	Oppenheimer	Outperform
2023-12-15	Herabstufung	H.C. Wainwright	Buy → Neutral
2023-12-15	Herabstufung	Jefferies	Buy → Hold
2023-12-15	Herabstufung	Leerink Partners	Outperform → Market Perform
2023-12-14	Herabstufung	BofA Securities	Buy → Underperform
2023-12-14	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2023-12-14	Herabstufung	Piper Sandler	Overweight → Neutral
2023-12-14	Herabstufung	Robert W. Baird	Outperform → Neutral
2023-12-14	Herabstufung	William Blair	Outperform → Mkt Perform
2023-11-15	Eingeleitet	William Blair	Outperform
2023-08-28	Eingeleitet	H.C. Wainwright	Buy
2023-07-03	Eingeleitet	BofA Securities	Buy
2022-09-19	Fortgesetzt	H.C. Wainwright	Buy
2022-01-27	Eingeleitet	Robert W. Baird	Outperform
2021-12-21	Eingeleitet	H.C. Wainwright	Buy
2021-11-22	Eingeleitet	Ladenburg Thalmann	Buy
2021-05-04	Eingeleitet	Jefferies	Buy
2021-05-04	Eingeleitet	Piper Sandler	Overweight
2021-05-04	Eingeleitet	SVB Leerink	Outperform

Alle ansehen

Reneo Pharmaceuticals Inc Aktie (RPHM) Neueste Nachrichten

Jan 10, 2025

Reneo Pharmaceuticals stock hits 52-week low at $7.64 - Investing.com India

Jan 10, 2025

Dec 24, 2024

Reneo Pharmaceuticals stock hits 52-week low at $7.91 By Investing.com - Investing.com Nigeria

Dec 24, 2024

Dec 23, 2024

Analysis of TANG CAPITAL MANAGEMENT LLC's Recent Transaction in Reneo Pharmaceuticals Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Highbridge Capital Management LLC Increases Stake in Reneo Pharm - GuruFocus.com

Nov 14, 2024

Nov 07, 2024

Form 424B3 OnKure Therapeutics, - StreetInsider.com

Nov 07, 2024

Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024

Oct 31, 2024

Reneo Pharmaceuticals (NASDAQ:RPHM) Stock Price Up 5.2% – Here’s What Happened - Defense World

Oct 31, 2024

Oct 28, 2024

Octagon Capital Advisors LP Adjusts Stake in Reneo Pharmaceutica - GuruFocus.com

Oct 28, 2024

Oct 24, 2024

Deep Track Capital, LP's Strategic Acquisition in Reneo Pharmace - GuruFocus.com

Oct 24, 2024

Oct 19, 2024

Analysts Offer Predictions for OKUR Q1 Earnings - Defense World

Oct 19, 2024

Oct 18, 2024

What is HC Wainwright's Estimate for OKUR Q1 Earnings? - MarketBeat

Oct 18, 2024

Oct 17, 2024

OnKure Therapeutics (NASDAQ:OKUR) Earns Buy Rating from HC Wainwright - MarketBeat

Oct 17, 2024

Oct 14, 2024

OnKure Therapeutics (OKUR) Stock Rebounds In Extended Session - Stocks Telegraph

Oct 14, 2024

Oct 11, 2024

Cormorant Asset Management's Strategic Acquisition of Reneo Pharmaceuticals Shares - Yahoo Finance

Oct 11, 2024

Deep Track Capital's Strategic Investment in Reneo Pharmaceuticals - Yahoo Finance

Oct 11, 2024

Deep Track Capital's Strategic Investment in Reneo Pharmaceutica - GuruFocus.com

Oct 11, 2024

OnKure shares initiated with Outperform rating on drug potential - Investing.com India

Oct 11, 2024

Perceptive Advisors LLC Acquires New Stake in Reneo Pharmaceuticals Inc - Yahoo Finance

Oct 11, 2024

Oct 10, 2024

Carlyle Group Inc. Reduces Stake in Reneo Pharmaceuticals Inc. - GuruFocus.com

Oct 10, 2024

Recently Listed Cancer Firm OnKure’s Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm - EMEA Tribune, Breaking News, World News, Latest News, Top Headlines

Oct 10, 2024

OnKure shares initiated with Outperform rating on drug potential By Investing.com - Investing.com Canada

Oct 10, 2024

Oct 08, 2024

Reneo Pharmaceuticals Completes Merger and Name Change to OnKure Therapeutics, Inc. - MarketBeat

Oct 08, 2024

Reneo Pharmaceuticals: Navigating Financial Challenges and Corporate Changes - TipRanks

Oct 08, 2024

Newley merged OnKure raises $65 million - The Pharma Letter

Oct 08, 2024

Oct 07, 2024

Boulder’s OnKure goes public with merger; key drug trial underway - Boulder Daily Camera

Oct 07, 2024

OnKure and Reneo Pharmaceuticals complete merger - Yahoo Finance

Oct 07, 2024

Oct 05, 2024

Reneo Pharmaceuticals stockholders approval merger with OnKure - TipRanks

Oct 05, 2024

Oct 04, 2024

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million - ForexTV.com

Oct 04, 2024

Reneo stockholders approve merger with OnKure - MSN

Oct 04, 2024

Oct 03, 2024

Reneo Pharmaceuticals secures stockholder approval for OnKure merger By Investing.com - Investing.com Australia

Oct 03, 2024

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure - StockTitan

Oct 03, 2024

Reneo Pharmaceuticals' Shareholders Approve Merger With OnKure; Reverse Stock Split Imminent - Marketscreener.com

Oct 03, 2024

Oct 02, 2024

Reneo Pharmaceuticals secures stockholder approval for OnKure merger - Investing.com India

Oct 02, 2024

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure - Benzinga

Oct 02, 2024

Point72 Asia Singapore Pte. Ltd. Takes Position in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) - Defense World

Oct 02, 2024

Oct 01, 2024

Nantahala Capital Management LLC Invests $846,000 in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) - Defense World

Oct 01, 2024

Sep 27, 2024